Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS
· Delayed Price · Currency is USD
0.190
0.00 (0.00%)
Jun 26, 2026, 3:53 PM EST
Northwest Biotherapeutics Employees
Northwest Biotherapeutics had 105 employees as of December 31, 2025. The number of employees increased by 80 or 320.00% compared to the previous year.
Employees
105
Change (1Y)
80
Growth (1Y)
320.00%
Revenue / Employee
$14,257
Profits / Employee
-$431,133
Market Cap
321.58M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CytoDyn | 13 |
| Silence Therapeutics | 88 |
| Vaxart | 65 |
| Cell Source | 1 |
| Nuo Therapeutics | 10 |
| Vicapsys Life Sciences | 2 |
Northwest Biotherapeutics News
- 2 months ago - Northwest Biotherapeutics names Annalisa Jenkins as strategic advisor - TheFly
- 2 months ago - Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform - PRNewsWire
- 2 months ago - Northwest Biotherapeutics establishes dedicated leukapheresis clinic - TheFly
- 2 months ago - Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic - PRNewsWire
- 7 months ago - Northwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK Facility - PRNewsWire
- 8 months ago - Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed - PRNewsWire
- 10 months ago - Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd. - PRNewsWire
- 11 months ago - Northwest Biotherapeutics announces passing of general counsel Les Goldman - TheFly